2 stories about Neuorology
NeuraLight team

NeuraLight secures $25 million Series A to develop precision medicine for neurological diseases

24.05.22|Meir Orbach
The company leverages oculometric data and uses computer vision and smartphones to measure the progression of neurological disorders such as Alzheimer’s, Parkinson’s, MS, and ALS
מיכה ברקסטון NeuraLight

How can startups leverage controversial FDA approval for Alzheimer’s drug?

17.06.21|Dr. Micha Breakstone
The decision to approve Biogen's Alzheimer’s drug signifies a watershed moment for neurology, highlighting an unprecedented opportunity for neurology-focused startups